🇯🇵·Jan 1, 1970CDMO
Apr 22,2026 | FJ3, API Manufacturing Building for Small Molecule and Macrocyclic Peptide Drugs at the Fujieda Plant, Receives the 2026 Facility of the Year Awards from ISPE in the Honorable Mention Category | News | CHUGAI PHARMACEUTICAL CO., LTD.
Publisher
C
Chugai Pharmaceutical
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Chugai Pharmaceutical
- Region
- Japan
- Scope
- CDMO
- Published
- January 1, 1970
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on chugai-pharm.co.jp
Leave the platform to read the original full article on the publisher site.
Source: Chugai Pharmaceutical
Scope: CDMO
Related coverage
More related coverage
McGill Faculty of Medicine News·13h ago
FMHS events and calls for submission
Pharmaceutical Executive·13h ago
Zepzelca Fails to Meet Main Goal of Phase III Lagoon Trial in Second-Line Small Cell Lung Cancer
OrthoPediatrics·13h ago
Pediatric Plating Platform™ | Hip (Trauma)
McGill Faculty of Medicine News·13h ago